Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Roivant Sciences Ltd (ROIV)

Roivant Sciences Ltd (ROIV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,371,425
  • Shares Outstanding, K 727,950
  • Annual Sales, $ 124,800 K
  • Annual Income, $ 4,349 M
  • EBIT $ 4,333 M
  • EBITDA $ 4,355 M
  • 60-Month Beta 1.25
  • Price/Sales 68.19
  • Price/Cash Flow N/A
  • Price/Book 1.54

Options Overview Details

View History
  • Implied Volatility 30.57% ( -5.71%)
  • Historical Volatility 32.86%
  • IV Percentile 12%
  • IV Rank 31.32%
  • IV High 59.67% on 02/20/24
  • IV Low 17.31% on 07/12/24
  • Put/Call Vol Ratio 0.07
  • Today's Volume 160
  • Volume Avg (30-Day) 1,364
  • Put/Call OI Ratio 0.68
  • Today's Open Interest 32,705
  • Open Int (30-Day) 36,706

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.30
  • Number of Estimates 3
  • High Estimate -0.22
  • Low Estimate -0.39
  • Prior Year -0.26
  • Growth Rate Est. (year over year) -15.38%

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.41 +1.40%
on 12/20/24
12.94 -10.55%
on 11/25/24
+0.08 (+0.70%)
since 11/20/24
3-Month
11.05 +4.75%
on 11/18/24
12.94 -10.55%
on 11/25/24
-0.40 (-3.34%)
since 09/20/24
52-Week
9.69 +19.40%
on 02/05/24
13.06 -11.37%
on 09/09/24
+1.61 (+16.16%)
since 12/20/23

Most Recent Stories

More News
Kinevant Sciences Announces Topline Results from Phase 2 RESOLVE-Lung Study of Namilumab in Chronic Active Pulmonary Sarcoidosis

ROIVW : 2.75 (-3.85%)
ROIV : 11.57 (+0.61%)
Roivant Announces Topline Results from Phase 2 RESOLVE-Lung Study of Namilumab in Chronic Active Pulmonary Sarcoidosis

ROIVW : 2.75 (-3.85%)
ROIV : 11.57 (+0.61%)
Insider Sale: President & COO of $ROIV (ROIV) Sells 100,000 Shares

Eric Venker, the President & COO of $ROIV ($ROIV), sold 100,000 shares of the company on 11-20-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 14.2% of their...

ROIV : 11.57 (+0.61%)
Roivant Reports Financial Results for the Second Quarter Ended September 30, 2024, and Provides Business Update

ROIVW : 2.75 (-3.85%)
ROIV : 11.57 (+0.61%)
Roivant to Report Financial Results for the Second Quarter Ended September 30, 2024 and Provide Business Update on Tuesday, November 12, 2024

ROIVW : 2.75 (-3.85%)
ROIV : 11.57 (+0.61%)
Organon Completes Acquisition of Dermavant, including Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1%

ROIVW : 2.75 (-3.85%)
ROIV : 11.57 (+0.61%)
Stocks Close Lower on Fears Fed Rate Cuts Will be Delayed

The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.72%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -1.00%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.94%. Stock indexes...

$SPX : 5,930.85 (+1.09%)
SPY : 591.15 (+1.20%)
$DOWI : 42,840.26 (+1.18%)
DIA : 428.54 (+1.24%)
$IUXX : 21,289.15 (+0.85%)
QQQ : 518.66 (+0.87%)
^BTCUSD : 98,593.41 (+2.04%)
ZNH25 : 108-310s (+0.33%)
HUM : 247.10 (+4.80%)
CVS : 44.36 (+1.32%)
UNH : 500.13 (+2.22%)
CNC : 59.58 (-0.22%)
Stocks Fall as Bond Yields Climb on Strong US Economic News

The S&P 500 Index ($SPX ) (SPY ) this morning is down -1.06%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.08%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.51%. Stock indexes this...

$SPX : 5,930.85 (+1.09%)
SPY : 591.15 (+1.20%)
$DOWI : 42,840.26 (+1.18%)
DIA : 428.54 (+1.24%)
$IUXX : 21,289.15 (+0.85%)
QQQ : 518.66 (+0.87%)
^BTCUSD : 98,593.41 (+2.04%)
ZNH25 : 108-310s (+0.33%)
HUM : 247.10 (+4.80%)
CVS : 44.36 (+1.32%)
UNH : 500.13 (+2.22%)
CNC : 59.58 (-0.22%)
Stocks Retreat as Bond Yields Jump on Diminished Fed Rate Cut Prospects

The S&P 500 Index ($SPX ) (SPY ) this morning is down -1.02%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.09%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.47%. Stock indexes this...

$SPX : 5,930.85 (+1.09%)
SPY : 591.15 (+1.20%)
$DOWI : 42,840.26 (+1.18%)
DIA : 428.54 (+1.24%)
$IUXX : 21,289.15 (+0.85%)
QQQ : 518.66 (+0.87%)
ZNH25 : 108-310s (+0.33%)
HUM : 247.10 (+4.80%)
CVS : 44.36 (+1.32%)
UNH : 500.13 (+2.22%)
ELV : 365.96 (-0.14%)
CNC : 59.58 (-0.22%)
Stocks Settle Higher on Lower Bond Yields and Quarter-End Window Dressing

The S&P 500 Index ($SPX ) (SPY ) Wednesday closed up +0.86%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.22%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.39%. Stock indexes...

$SPX : 5,930.85 (+1.09%)
SPY : 591.15 (+1.20%)
$DOWI : 42,840.26 (+1.18%)
DIA : 428.54 (+1.24%)
$IUXX : 21,289.15 (+0.85%)
QQQ : 518.66 (+0.87%)
ZNH25 : 108-310s (+0.33%)
CTAS : 186.94 (+2.27%)
MRK : 98.05 (-1.48%)
MRVL : 111.90 (+2.56%)
EXR : 147.00 (+3.27%)
MDT : 81.03 (+1.30%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Roivant Sciences is a biopharmaceutical company dedicated to improving the delivery of healthcare to patients. Roivant Sciences, formerly known as Montes Archimedes Acquisition Corp., is based in NEW YORK.

See More

Key Turning Points

3rd Resistance Point 11.95
2nd Resistance Point 11.81
1st Resistance Point 11.69
Last Price 11.57
1st Support Level 11.43
2nd Support Level 11.29
3rd Support Level 11.17

See More

52-Week High 13.06
Fibonacci 61.8% 11.77
Last Price 11.57
Fibonacci 50% 11.37
Fibonacci 38.2% 10.98
52-Week Low 9.69

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar